Two Brothers. One Mission.
To build the world’s first immune system
On any given day, 1 in 31 U.S. hospital patients has an infection they picked up in the hospital. It's a $45 billion problem that is responsible for more deaths than breast cancer or car accidents.1 4 5
The science was never the problem. It was the cost.
A team two decades in the making, and the technology Dirk built to make this possible.
Our Granny
She went in for a routine procedure. She came out with C. diff, then sepsis, then spent months in hospital. Nobody could tell us where it came from, and twenty-five years later, most hospitals still can't.
Dirk’s Path
Dirk spent six years at McMaster under Gerry Wright, a top antimicrobial resistance researcher, using DNA sequencing to find infectious disease and resistance genes across blood, sputum, wastewater, and World War II-era French military latrines. The science worked. It was just far too expensive to run continuously.
Kurt’s Path
Kurt wanted to build a company since he was a kid, and spent twenty years assembling the toolkit, from door-to-door pest control to investment banking to seven years as an investor. Most recently at Carlyle, where he led diligence across 350+ business models and put over $3Bn behind what he found. Building a scalable commercial model for a market that doesn't exist yet is exactly what he's built to do.
The Breakthrough
Dirk's doctoral research produced a breakthrough that cuts certain sequencing costs twentyfold, making proactive genomic intelligence commercially viable for the first time. So they took the leap with one mission: that no grandmother seeking care should have to worry about a preventable infection.
Welcome, Claryx
Claryx exists to fundamentally change the way hospital-acquired infections are detected, traced, and stopped.
Backed by the field’s most extraordinary
Robin Patel, MD, PhD
Chair, Clinical Microbiology, Mayo Clinic; Past President, American Society for Microbiology; Director, NIH Antibacterial Resistance Leadership Group Laboratory Center
.avif)
Dave Chokshi, MD
43rd Health Commissioner of New York City; CEO, NYC Health + Hospitals Accountable Care Organization; inaugural Chief Population Health Officer, NYC H+H
Jordan Peccia, PhD
Head, Benjamin Franklin College, Yale University; Thomas E. Golden Jr. Professor and former Chair, Chemical & Environmental Engineering
Yonatan Grad, MD, PhD
Director, Center for Communicable Disease Dynamics, Harvard T.H. Chan; Professor of Immunology & Infectious Diseases; Infectious Disease Physician, Brigham and Women's
Chris Mason, MD, PhD
WorldQuant Professor of Genomics, Weill Cornell Medicine; Director, WorldQuant Initiative for Quantitative Prediction; Co-Founder, Biotia and BioAstra
Rohit Chitale, PhD
Former Founding Director, Division of Integrated Biosurveillance, U.S. Department of Defense; Program Manager, Biological Technologies Office, DARPA
Gautam Dantas, PhD
Conan Professor and Division Co-Chief, Laboratory & Genomic Medicine, Washington University School of Medicine
Russel Kerbel, MD, MBA
Medical Director, Sepsis Prevention and Chair, Clinical Excellence, UCLA Health; Assistant Clinical Professor of Medicine, David Geffen School of Medicine at UCLA
Gerry Wright, PhD, FRSC
Founding Director, Institute for Infectious Disease Research and Executive Director, Global Nexus for Pandemics & Biological Threats, McMaster University
Talk To The Claryx Team
The Hospital Immune System